1. Home
  2. RYTM vs PNFP Comparison

RYTM vs PNFP Comparison

Compare RYTM & PNFP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RYTM
  • PNFP
  • Stock Information
  • Founded
  • RYTM 2008
  • PNFP 2000
  • Country
  • RYTM United States
  • PNFP United States
  • Employees
  • RYTM N/A
  • PNFP N/A
  • Industry
  • RYTM Biotechnology: Pharmaceutical Preparations
  • PNFP Major Banks
  • Sector
  • RYTM Health Care
  • PNFP Finance
  • Exchange
  • RYTM Nasdaq
  • PNFP Nasdaq
  • Market Cap
  • RYTM 6.4B
  • PNFP 6.6B
  • IPO Year
  • RYTM 2017
  • PNFP N/A
  • Fundamental
  • Price
  • RYTM $98.54
  • PNFP $88.31
  • Analyst Decision
  • RYTM Strong Buy
  • PNFP Buy
  • Analyst Count
  • RYTM 12
  • PNFP 14
  • Target Price
  • RYTM $117.00
  • PNFP $112.23
  • AVG Volume (30 Days)
  • RYTM 629.6K
  • PNFP 1.1M
  • Earning Date
  • RYTM 11-04-2025
  • PNFP 10-15-2025
  • Dividend Yield
  • RYTM N/A
  • PNFP 1.09%
  • EPS Growth
  • RYTM N/A
  • PNFP 49.26
  • EPS
  • RYTM N/A
  • PNFP 7.83
  • Revenue
  • RYTM $174,334,000.00
  • PNFP $1,885,186,000.00
  • Revenue This Year
  • RYTM $46.10
  • PNFP $31.11
  • Revenue Next Year
  • RYTM $63.02
  • PNFP $119.44
  • P/E Ratio
  • RYTM N/A
  • PNFP $11.24
  • Revenue Growth
  • RYTM 54.92
  • PNFP 21.58
  • 52 Week Low
  • RYTM $45.91
  • PNFP $81.57
  • 52 Week High
  • RYTM $116.00
  • PNFP $131.91
  • Technical
  • Relative Strength Index (RSI)
  • RYTM 39.87
  • PNFP 51.41
  • Support Level
  • RYTM $95.27
  • PNFP $84.06
  • Resistance Level
  • RYTM $102.20
  • PNFP $87.38
  • Average True Range (ATR)
  • RYTM 4.86
  • PNFP 1.96
  • MACD
  • RYTM -1.75
  • PNFP 0.53
  • Stochastic Oscillator
  • RYTM 17.51
  • PNFP 85.10

About RYTM Rhythm Pharmaceuticals Inc.

Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.

About PNFP Pinnacle Financial Partners Inc.

Pinnacle Financial Partners Inc is a financial holding company. The company operates through its wholly-owned subsidiary, Pinnacle Bank. The bank provides a full range of lending products, including commercial, real estate, and consumer loans to individuals and small to medium-sized businesses. It operates as a community bank mainly in the urban markets of Nashville, Knoxville, Memphis, and Chattanooga, Tennessee, as well as surrounding counties. It relies heavily on mergers and acquisitions. A majority of its loan portfolio is in commercial loans, mainly real estate, as well as industrial loans. The bank generates a majority of its net revenue through net interest income.

Share on Social Networks: